Rifaximin

6 trials 3 recruiting AGastroenterology Orphan designation

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

2 Completed trials

6 Sponsors

9 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 4 Phase IV: 1

Indications tested

Hepatic encephalopathy 1 Parkinson's disease 1 Non-small cell lung cancer 1

Sponsors using this IMP

Amsterdam UMC Stichting 1 Fondazione Santa Lucia IRCCS 1 Fundacion GECP 1 Salix Pharmaceuticals Inc. 1 Stichting Radboud University Medical Center 1 UZ Leuven 1

All trials

6 total

Can the Gut Help Fight Addiction? A Clinical Study on Rifaximin and the Microbiota–Brain Connection Not authorised

2025-524778-41-00 Phase II 1 country Fondazione Santa Lucia
Phase II study on the safety and feasibility of stool transplants in limited non-small cell lung cancer patients, using donors who responded… Recruiting

2025-521251-24-00 Phase II 1 country Fundacion GECP
The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi… Recruiting

2024-512040-28-01 Phase IV 2 countries Amsterdam UMC Stichting
Management of Parkinson's disease if levodopa is broken down prematurely Recruiting

2024-510629-24-00 Phase II 1 country Stichting Radboud University Medical Center
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) Ended

2022-502899-23-00 Phase III 8 countries Salix Pharmaceuticals Inc.
MoodBugs_Rifaximin Ended

2024-517808-11-00 Phase II 1 country UZ Leuven

Showing 1–6 of 6 trials

← All drugs A–Z